The growing trend of novel psychoactive substances (NPS), often dubbed "designer drugs," presents a significant challenge to global public health and law enforcement. These compounds, frequently synthesized to circumvent existing drug laws, swiftly appear on the market and are marketed as "legal highs" or "research chemicals," attracting individual